細胞冷凍保存市場：按產品類型、應用、最終用戶和地區分類。

Cell Cryopreservation Market, By Product Type, By Application, By End User, By Geography

出版日期: 2026年04月01日 | 出版商:

Coherent Market Insights | 英文 154 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，細胞冷凍保存市場規模將達到153.5億美元，2033年將達到668.9億美元。預計從2026年到2033年，該市場將以23.4%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	153.5億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	23.40%	2033年市場規模預測：	668.9億美元

細胞冷凍保存是一種利用液態氮將細胞冷卻至極低溫度（通常低於-80 度C）以保存細胞的技術。這使得細胞能夠在不損害其活性的前提下長期保存。癌症和遺傳疾病發生率的上升、再生醫學研究投入的增加、幹細胞庫的建立、不孕症治療以及組織工程等領域的發展，都可能推動研究機構和醫院對細胞冷凍保存技術的需求。冷凍保存設備和解決方案的技術進步也將促進市場成長。然而，冷凍保存程序和設備的高成本可能會在預測期內阻礙市場成長。

市場動態

全球細胞冷凍保存市場成長的主要驅動力是慢性病和危及生命的疾病發生率的上升。癌症和遺傳性疾病在全球範圍內的日益普遍，推動了對高度依賴冷凍保存細胞的研究活動、細胞療法和臨床試驗的需求。根據世界癌症研究基金會（WCRF）統計，2021年全球報告了約1,800萬例新增癌症病例。此外，公共和私人對再生醫學、幹細胞研究以及醫學生物技術創新領域的投資增加，也促進了冷凍保存技術的應用。然而，冷凍保存設備、液態氮以及整個流程的高成本可能會阻礙市場成長。熟練專業人員的短缺以及慢速冷卻過程中的技術挑戰也可能阻礙市場成長。機器人冷凍保存技術和設備的持續發展有望帶來可觀的成長機會。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對全球細胞冷凍保存市場的主要參與者進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份全球細胞冷凍保存市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等產業相關人員。
相關人員可以透過利用分析全球細胞冷凍保存市場中使用的各種策略矩陣，更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

公司簡介
- Thermo Fisher Scientific Inc.
- Merck KGaA
- GE Healthcare
- Lonza Group Ltd.
- STEMCELL Technologies Inc.
- BioLife Solutions, Inc.
- Cryolife, Inc.
- Organ Recovery Systems Inc.
- Custom Biogenic Systems
- Sartorius AG
- Takara Bio Inc.
- Chart Industries, Inc.
- Biocision, LLC
- Cardinal Health, Inc.
- Helmer Scientific

第9章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第10章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI1698

Cell Cryopreservation Market is estimated to be valued at USD 15.35 Bn in 2026 and is expected to reach USD 66.89 Bn by 2033, growing at a compound annual growth rate (CAGR) of 23.4% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 15.35 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	23.40%	2033 Value Projection:	USD 66.89 Bn

Cell cryopreservation involves preserving cells by cooling them to extremely low temperatures, usually -80°C or below using liquid nitrogen. It helps to preserve cells for a very long period of time without affecting their viability. Factors such as rising prevalence of cancers and genetic disorders, increasing investments in regenerative medicine research, stem cell banking, fertility preservation and tissue engineering can boost demand for cell cryopreservation processes across research institutes and hospitals. Technological advancements in cryopreservation equipment and solutions can also drive the market growth. However, high costs associated with cryopreservation procedures and equipment can hamper the market growth during the forecast period.

Market Dynamics

Global cell cryopreservation market growth is mainly driven by rising incidence of chronic and life-threatening diseases. Growing prevalence of cancers and genetic disorders globally boosts demand for research activities, cell therapies and clinical trials which heavily rely on cryopreserved cells. According to the World Cancer Research Fund, approximately 18 million new cancer cases were reported globally in 2021. Furthermore, increasing investments by both public and private players in regenerative medicine, stem cell research and medical biotech innovations have also boosted the uptake of cryopreservation processes. However, high costs associated with cryopreservation equipment, liquid nitrogen and overall procedures can hamper the market growth. Lack of skilled professionals and technical challenges during slow freezing processes can also hamper the market growth. Ongoing developments in robotic cryostorage technologies and equipment can offer lucrative market growth opportunities.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cell cryopreservation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, GE Healthcare, Lonza Group Ltd., STEMCELL Technologies Inc., BioLife Solutions, Inc., Cryolife, Inc., Organ Recovery Systems Inc., Custom Biogenic Systems, Sartorius AG, Takara Bio Inc., Chart Industries, Inc., Biocision, LLC, Cardinal Health, Inc., Helmer Scientific
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global cell cryopreservation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell cryopreservation market

Market Segmentation

By Product Type (Revenue, USD Bn, 2021 - 2033)
Cryoprotectant Agents
- Glycerol
- Dimethyl Sulfoxide (DMSO)
- Others
Equipment
- Incubators
- Liquid Nitrogen Supply Tanks
- Freezers
- Others
By Application (Revenue, USD Bn, 2021 - 2033)
Stem Cells
Oocytes and Embryotic cells
Sperm Cells
Hepatocytes
Others
By End User (Revenue, USD Bn, 2021 - 2033)
Biopharmaceutical & Pharmaceutical Companies
Research Institutes
Biobanks
IVF clinics
Others
By Region (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Company Profiles
Thermo Fisher Scientific Inc.
Merck KGaA
GE Healthcare
Lonza Group Ltd.
STEMCELL Technologies Inc.
BioLife Solutions, Inc.
Cryolife, Inc.
Organ Recovery Systems Inc.
Custom Biogenic Systems
Sartorius AG
Takara Bio Inc.
Chart Industries, Inc.
Biocision, LLC
Cardinal Health, Inc.
Helmer Scientific

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Cell Cryopreservation Market, By Product Type, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Cryoprotectant Agents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  - Glycerol
  - Dimethyl Sulfoxide (DMSO)
  - Others
Equipment
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  - Incubators
  - Liquid Nitrogen Supply Tanks
  - Freezers
  - Others

5. Global Cell Cryopreservation Market, By Application, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Stem Cells
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Oocytes and Embryotic cells
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Sperm Cells
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Hepatocytes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Cell Cryopreservation Market, By End User, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Biopharmaceutical & Pharmaceutical Companies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Biobanks
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
IVF clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Cell Cryopreservation Market, By Region, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Thermo Fisher Scientific Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Merck KGaA
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- GE Healthcare
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Lonza Group Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- STEMCELL Technologies Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- BioLife Solutions, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Cryolife, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Organ Recovery Systems Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Custom Biogenic Systems
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Sartorius AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Takara Bio Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Chart Industries, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Biocision, LLC
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Cardinal Health, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Helmer Scientific
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies